Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Novartis Venture Fundnvfund.comNovartis Venture Fund (NVF) is the life-science–focused venture arm of Novartis that invests in biotechnology and biopharmaceuticals at various growth stages. It manages over USD 750 million in committed capital and more than 40 portfolio companies across North America and Europe, aiming to foster innovation, deliver patient benefit, and generate superior returns. Based in Basel, Switzerland and Cambridge, Massachusetts, NVF takes a hands-on approach, partnering with boards and management to develop novel therapeutics and platforms that address unmet clinical needs.
The market map
Biotech and Health Service Providers →Where AI ranks Novartis Venture Fund
